On-Demand Panel Discussion
The United States healthcare system has a serious infectious disease management problem. The antibiotic resistance crisis is widespread, serious, costly, and deadly. Delays in pathogen identification lead to poor clinical outcomes, including increased mortality risk. And, optimally managing outbreaks is critical to health systems whose reimbursement is tied to the health of a population, such as ACOs.
Listen to an informative panel discussion with industry leaders on the issues surrounding the infectious disease management crisis. Eleanor Herriman, MD, MBA, Chief Medical Informatics Officer at Viewics speaks with Margret Oethinger, MD, Ph.D., Medical Director of Providence Health & Services, and Susan E. Sharp, Ph.D., DABMM, FAAM, Regional Director of Microbiology and the Molecular Infectious Disease Laboratories, Department of Pathology, Kaiser Permanente and President-Elect, American Society for Microbiology. They cover the current state of infectious disease management in the U.S., and what can be done to improve it.
Dr. Sharp received her B.S. in Medical Technology and her M.S. in Medical Microbiology & Biochemistry from the University of Nebraska Medical Center in Omaha, Nebraska. She received her Ph.D. in Veterinary Microbiology and Parasitology from the Veterinary School of Medicine, Texas A&M University in College Station, Texas. She then did a 2-year post-doctorate fellowship in Clinical Microbiology in the Department of Pathology, Division of Microbiology, at Hartford Hospital in Hartford, Connecticut. Dr. Sharp has been a clinical microbiologist and a very active member of The American Society for Microbiology (ASM) for 30 years serving on various boards and committees. She is a Diplomat of the American Board of Medical Microbiology, a Fellow in the American Academy of Microbiology, and was selected as the 2012 bioMerieux Sonnenwirth laureate, ASM’s highest award given for leadership in clinical microbiology. Dr. Sharp serves as an Advisor to the CLSI Antimicrobial Susceptibility Testing Sub-Committee and is a member of the Board of Scientific Councilors for the Office of Infectious Diseases of the CDC. Dr. Sharp is the current President-Elect of ASM.
A native of Germany, Dr. Oethinger completed her preclinical studies at the University of Göttingen and received her M.D. and Ph.D. in Endocrinology from the Medical University of Lübeck in Germany. She was a Resident in Internal Medicine and then in Medical Microbiology at the University of Ulm. She pursued a Research Fellowship with Dr. Stuart Levy at the Center for Drug Resistance and Adaptation Genetics at Tufts University School of Medicine, returning to Germany to direct a Clinical Microbiology Laboratory at the Heart Transplant Center in Bad Oeynhausen, Germany. Upon returning to the United States, Dr. Oethinger served as a Resident in Clinical Pathology at Yale University. After her Residency, she first did a Clinical Pathology Research Fellow at Yale and then completed a Clinical Microbiology Fellowship at the Cleveland Clinic. She is Board Certified in Clinical Pathology as well as Medical Microbiology. Her interests are Molecular Diagnostics, Bacterial Antibiotic Resistance and Infectious Diseases Pathology.
Eleanor Herriman, MD, MBA is a former Senior Fellow with Professor Michael Porter at Harvard Business School’s Institute for Strategy and Competitiveness. Prior career experience includes: market research and strategy services to the pathology and laboratory industries at G2 Intelligence, healthcare strategy consulting at Bain & Company, and multiple startup medical technology ventures. Dr. Herriman holds a Doctor of Medicine degree from Baylor College of Medicine and was awarded the President’s Scholarship. She also holds a Masters in Business Administration from Harvard University Graduate School of Business Administration as a Baker Scholar and a Bachelors of Science in electrical engineering from Rice University, Magna Cum Laude, with a minor in bioengineering.
You’ll learn about:
- The magnitude of the U.S. health system’s infectious disease management problem
- The most serious concerns and trends for healthcare institutions and communities across the nation
- The most promising solutions to health systems’ most urgent infectious disease management challenges
You may also be interested in: